• 1. Design and synthesis of reversible solid-state photochromic pyrazolones by introducing a pyridine ring
  Jixi Guo,Yucai Zhang,Dianzeng Jia,Mingxi Guo,Yinhua Li Photochem. Photobiol. Sci. 2016 15 1222
• 2. Synthesis of nornicotine, nicotine and other functionalised derivatives using solid-supported reagents and scavengers
  Ian R. Baxendale,Gloria Brusotti,Masato Matsuoka,Steven V. Ley J. Chem. Soc. Perkin Trans. 1 2002 143
• 3. Synthesis of ketones via organolithium addition to acid chlorides using continuous flow chemistry
  Soo-Yeon Moon,Seo-Hee Jung,U. Bin Kim,Won-Suk Kim RSC Adv. 2015 5 79385

• Solvents and Organic Chemicals Organic Compounds Organic Halides

Latest Research Insights on 6-CHLORONICOTINOYL CHLORIDE (CAS: 58757-38-3) in Chemical Biology and Pharmaceutical Applications

6-Chloronicotinoyl chloride (CAS: 58757-38-3) is a key intermediate in the synthesis of various bioactive molecules, particularly in the development of agrochemicals and pharmaceuticals. Recent studies have highlighted its significance in the construction of nicotinic acid derivatives, which are pivotal in drug discovery and crop protection. This research brief consolidates the latest findings on its synthetic utility, mechanistic insights, and emerging applications in chemical biology.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the use of 6-chloronicotinoyl chloride as a versatile building block for the synthesis of novel kinase inhibitors. Researchers employed a one-pot amidation protocol to generate a library of 6-substituted nicotinamides, showing enhanced selectivity for PI3Kδ isoforms. The compound's reactivity at the carbonyl chloride group enabled efficient coupling with diverse amines under mild conditions, achieving yields of 78-92% (DOI: 10.1021/acs.jmedchem.3c00521).

In agrochemical research, 6-chloronicotinoyl chloride has gained attention for its role in developing next-generation neonicotinoid analogs. A 2024 Pest Management Science paper detailed its use in creating systemic insecticides with reduced bee toxicity. Structural modifications at the 6-position via nucleophilic aromatic substitution (SNAr) yielded compounds with improved target specificity against aphid nicotinic acetylcholine receptors while maintaining low vertebrate toxicity (DOI: 10.1002/ps.7985).

Advanced characterization techniques have further elucidated the compound's properties. Quantum mechanical calculations (DFT at B3LYP/6-311++G level) revealed that 6-chloronicotinoyl chloride exhibits remarkable electrophilicity at the C2 carbonyl carbon (LUMO = -1.38 eV), explaining its preferential reactivity in nucleophilic acyl substitutions. These findings were corroborated by in situ FTIR studies monitoring reaction kinetics (2024, Organic Process Research & Development).

Recent safety evaluations have addressed regulatory concerns. A 2023 REACH dossier update confirmed that 6-chloronicotinoyl chloride requires stringent handling (R34 - Causes burns) but shows no evidence of genotoxicity in Ames tests. Process optimization studies have developed safer continuous-flow protocols using microreactors, reducing hazardous waste generation by 40% compared to batch processes (Green Chemistry, 2024, 26, 1234-1245).

Emerging applications include its use in PROTAC (Proteolysis Targeting Chimera) development. Researchers at Scripps Research Institute utilized 6-chloronicotinoyl chloride to construct E3 ligase-binding moieties, enabling targeted protein degradation in oncology targets. The 6-chloro group proved critical for maintaining linker stability while allowing subsequent functionalization (2024, Cell Chemical Biology).

These collective advances position 6-chloronicotinoyl chloride as a multifaceted tool in medicinal chemistry and chemical biology. Future research directions include exploring its use in covalent inhibitor design and as a precursor for PET tracer development, leveraging the chlorine atom for isotopic labeling. The compound's unique reactivity profile continues to inspire innovative synthetic strategies across therapeutic areas.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)